ÂÜÀòÂÒÂ×

He Zhou is leading the global efforts in pharmacology to support the company’s internal pipeline. She brings more than 18 years of experience in Immuno-Oncology. Before joining HiFiBiO Therapeutics, Dr. Zhou participated in the clinical development of multiple Immuno-Oncology drugs at different stages as Senior Director of Clinical Biomarkers at BeiGene Ltd. in Beijing, China. Prior to working at BeiGene, she also served as Vice President of Biology, Pharmacology and Toxicology at Tayu Huaxia Biotech Medical Group Co. Ltd., Executive Director and Head of Pharmacology at Shanghai ChemPartner Co. Ltd., and Senior Scientist at Momenta Pharmaceuticals Inc.

Dr. Zhou received a bachelor’s degree in medicine and a master’s degree in Immunology from Beijing University Health Science Center (formerly Beijing Medical University), as well as a PhD degree in Immunology from the University of Mississippi Medical Center. She received her postdoc training in Dr. Ralph Reisfeld’s Laboratory in Immuno-Oncology at The Scripps Research Institute.